Emerald Advisers, LLC Pacira Bio Sciences, Inc. Transaction History

Emerald Advisers, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 03, 2023	SELL	$38.19 - $57.45 $10.3 Million - $15.5 Million	-269,671 Reduced 54.56%	224,625 $8.67 Million
Q3 2022 Oct 25, 2022	BUY	$51.24 - $58.89 $7.95 Million - $9.13 Million	155,076 Added 45.72%	494,296 $26.3 Million
Q2 2022 Jul 29, 2022	BUY	$51.49 - $81.64 $1.76 Million - $2.79 Million	34,172 Added 11.2%	339,220 $19.8 Million
Q1 2022 Apr 29, 2022	BUY	$60.03 - $76.49 $18.3 Million - $23.3 Million	305,048 New	305,048 $23.3 Million

263

50.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Emerald Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Emerald Advisers, LLC with notifications on news.